|Chemical and physical data|
|Molar mass||256.9 kDa|
Vobarilizumab (INN) is a humanized monoclonal antibody designed for the treatment of inflammatory autoimmune diseases.
This drug was developed by Ablynx NV.
- Statement On A Nonproprietary Name Adopted By The USAN Council - Vobarilizumab, American Medical Association.
- World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 114" (PDF). WHO Drug Information. 29 (4).